Skip to main content
Fig. 4 | Cost Effectiveness and Resource Allocation

Fig. 4

From: Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case

Fig. 4

(Source: Data are from July 2011 to December 2015, SISMED 2011–2015)

Price indexes and real health expenditure for immunosuppressive and insulin therapies. For immunosuppressive therapy indexes include the following ATC: L04AA23, L04AA24, L04AB01, L04AB02, L04AB04, and L04AC07. For insulin therapy indexes include the following ATC: A10AB01, A10AB04, A10AB06, A10AC01, A10AD01, A10AD01, A10AD04 and A10AE04

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us